Body Lice
Clinical Snapshot
Body lice (pediculosis corporis) is caused by Pediculus humanus corporis (also called Pediculus humanus humanus), a subspecies of the human louse that can interbreed with head lice biologically but is an entirely distinct clinical and epidemiological condition: unlike head lice (Pediculus humanus capitis) and pubic lice (Phthirus pubis), which live directly on the host, body lice live and lay their eggs (nits) in the seams and folds of worn clothing and bedding, leaving that habitat only to take a blood meal from the skin several times a day before returning to the fabric.[1]
This single fact drives almost everything distinctive about the condition. Body lice infestation occurs specifically where clothing is worn for extended periods without laundering or changing — a marker of limited access to regular bathing and clean clothing rather than a failure of personal hygiene — and is essentially unheard of in people with reliable, regular access to laundry facilities.[1] It is also the clinically most consequential of the three human lice, because the body louse — and only the body louse — is a proven vector for three serious systemic bacterial diseases: epidemic typhus (Rickettsia prowazekii), trench fever (Bartonella quintana), and louse-borne relapsing fever (Borrelia recurrentis).[2][3] A 2020-2021 surveillance study of persons experiencing homelessness in inner-city Winnipeg, led by the Public Health Agency of Canada, found body lice positive for B. quintana in 1 of 7 participants sampled — a concrete reminder that these pathogens are a real, current concern in Canadian shelter and street-involved populations, not only a historical or overseas one.[4]
This chapter covers body lice only. Head lice and pubic lice have different habitats, transmission routes, and management, and are covered in their own separate chapters.
Recognize the Condition
Symptoms
Intense, often relentless pruritus is the dominant and usually the presenting symptom, typically most severe over the trunk, shoulders, waist, and axillae — the areas where clothing seams contact skin most consistently — and commonly precedes any visible skin change.[1]
Skin findings
Bite reactions appear as erythematous macules, papules, or wheals with a central hemorrhagic punctum, concentrated in the areas above. Scratching commonly produces excoriations, and secondary bacterial infection (impetigo, cellulitis) is a genuine and common complication of chronic scratching, not a rare one.[1]
Vagabond's disease — the mark of a chronic, longstanding infestation
With prolonged, untreated infestation, repeated bites and scratching over the same clothing-contact areas — waist, groin, axillae, shoulders, upper back — produce a distinctive pattern of thickened, hyperpigmented, lichenified skin historically termed "vagabond's disease" (morbus errorum). Its presence signals a chronic infestation, not a recent or trivial one, and should prompt a direct, practical conversation about the patient's actual ongoing access to clean clothing and bathing rather than being treated as simply a more severe rash.[1]
Other findings
Cervical or regional lymphadenopathy and mild conjunctivitis are occasionally seen with heavier infestations. Lice or nits are only rarely found directly on body hair, and only with heavy, longstanding infestation — see Assessment & Diagnosis for where to actually look first.[1]
Risk Factors
- Homelessness or unstably housed/unsheltered living — the dominant risk factor, driven by limited access to regular bathing and clean-clothing changes rather than by any personal characteristic of the individual.[1]
- Crowded congregate settings with shared or infrequently laundered bedding/clothing — homeless shelters, refugee camps, and correctional facilities.[1]
- Situations of social disruption, displacement, or disaster response that interrupt normal access to laundry and bathing facilities, including historically war and mass population displacement — the setting in which epidemic typhus has caused its largest historical outbreaks.[5]
- Cold-climate settings where layered clothing is worn for extended periods without changing — a practical Canadian consideration for unsheltered individuals over the winter months.
- Severe poverty limiting access to a change of clothing or to laundry facilities/services.
- Chronic mental illness or substance use disorder, where these compound existing barriers to stable housing, bathing, and clothing access.
- Older age or reduced mobility/functional capacity limiting a person's ability to independently bathe or launder clothing.
- Any circumstance producing prolonged, unchanged use of the same clothing — this is the common final pathway across every risk factor above, not any one of them individually.
Red Flags & Refer
Body lice themselves are rarely dangerous, but the diseases the body louse can transmit are — screen for these specifically in any patient with confirmed or likely body lice exposure who has fever or a rash, rather than attributing the finding to the skin infestation alone:
- Abrupt high fever, chills, severe headache, and myalgia, followed 4-7 days later by a rash beginning on the trunk/axillae and spreading to the limbs while sparing the face, palms, and soles — evaluate for epidemic typhus (Rickettsia prowazekii). Case fatality is 10-40% without treatment for severe disease; start doxycycline without waiting for laboratory confirmation if the patient is seriously ill.[5][6]
- Recurring fever in cycles — febrile periods of 2-9 days alternating with afebrile periods of 2-4 days — evaluate for louse-borne relapsing fever (Borrelia recurrentis). Treat urgently, but in a setting equipped to monitor for the Jarisch-Herxheimer reaction, which occurs in over half of patients after the first antibiotic dose (see Choose Initial Treatment).[7][3]
- Prolonged or unexplained fever, a new heart murmur, or blood-culture-negative endocarditis in a patient with current or past body lice exposure or a history of homelessness — evaluate for Bartonella quintana bacteremia or endocarditis; over 90% of endocarditis cases require valvular surgery, and mortality remains meaningful (about 12%) even with treatment.[2]
- Signs of a spreading secondary bacterial skin infection — expanding erythema, warmth, purulence, or systemic signs — manage per the usual skin and soft tissue infection pathway.
- Any suspected or confirmed louse-borne systemic illness is reportable to public health. In Alberta, physicians and laboratories must notify the Medical Officer of Health of confirmed and probable cases of louseborne typhus or relapsing fever within 48 hours; confirm and follow the equivalent notifiable-disease requirement in your own province or territory, since these are not nationally notifiable and requirements vary.[5][7]
Assessment & Diagnosis
History
Ask directly, and without judgment, about the patient's actual current access to regular bathing and to laundering or changing clothing — housing status, shelter stays, and how frequently clothing is realistically changed are the most clinically relevant history here, more so than a general hygiene history.[1] Characterize the itching (onset, distribution, severity) and ask specifically about fever, rash, or joint pain in the recent past, since these change the encounter from a skin complaint into a possible systemic-infection assessment (see Red Flags & Refer).
Examination — look at the clothing, not just the skin
This is the central diagnostic pearl for body lice and the point most likely to be missed: body lice and their nits are found in the seams and folds of worn clothing, not on the skin or in hair.[1] With the patient's consent and in a private setting, examine the inner seams of the waistband, underarms, collar, and any other area of prolonged skin contact for live lice, nits glued to the fabric fibres, and small dark fecal specks — a magnifying lens is helpful for a light infestation. Blood staining on the fabric from feeding or scratching may also be visible. Only with heavy, longstanding infestation are lice occasionally also found directly on body hair — check for this specifically, since it changes management (see Choose Initial Treatment).[1]
On skin examination, look for the bite reactions, excoriations, and — in chronic infestation — the hyperpigmented, thickened skin of vagabond's disease described in Recognize the Condition.
Differential diagnosis
| Condition | Distinguishing features |
|---|---|
| Scabies | Burrows and intense nocturnal itching concentrated in finger webs, wrists, and genitals rather than trunk/waist; mites are found on skin, not clothing. Can coexist with body lice in the same patient. |
| Bed bug bites | Linear or clustered bite pattern, often on exposed skin (face, neck, arms); bed bugs live in bedding/furniture seams, not in clothing worn on the body. |
| Flea bites | Grouped bites typically on the lower legs; associated with pet or environmental exposure rather than worn clothing. |
| Contact or atopic dermatitis | No lice or nits found on careful clothing examination; distribution and morphology match a specific irritant/allergen exposure or an atopic pattern instead. |
| Drug eruption or viral exanthem | Temporal association with a new medication or a preceding viral prodrome; distribution not concentrated at clothing-contact points. |
Laboratory testing
No routine laboratory testing is needed to diagnose uncomplicated body lice — diagnosis is clinical, made by direct visualization on the clothing. Reserve testing for a patient with red-flag features suggesting a louse-borne systemic illness: paired acute/convalescent IFA serology or PCR for R. prowazekii; dark-field microscopy, a Giemsa-, Wright-, or acridine-orange-stained blood/bone marrow smear, or EIA serology for B. recurrentis; and blood culture or serology for B. quintana (an IgG titre over 1:800 predicts endocarditis).[5][7][2]
Treatment Targets
- Eliminate the louse population by decontaminating the actual clothing and bedding where lice and nits live — this is the primary, essential target of therapy, not an adjunct to a topical medication.
- Relieve pruritus and treat any secondary bacterial skin infection.
- Identify and treat body-hair infestation with a topical pediculicide specifically when lice or nits are actually found there, rather than by default.
- Recognize and urgently treat or refer any suspected louse-borne systemic illness — epidemic typhus, trench fever, or louse-borne relapsing fever — and meet the applicable public health notification requirement.
- Connect the patient with a genuinely sustainable source of clean clothing and bathing/laundering access, since this — not any medication — is what actually prevents recurrence.
- Deliver every part of this care in a respectful, non-stigmatizing way that treats body lice as a treatable medical condition tied to an access barrier, not a personal failing.
Choose Initial Treatment
The core intervention is decontaminating clothing and bedding — for every patient
Because body lice live in fabric and only visit the skin to feed, 1st line, for every patient hot-water machine wash (at least 50°C/130°F) followed by a high-heat dry cycle for all worn clothing and bedding; items that cannot be washed should be dry-cleaned or sealed in a plastic bag for at least 2 weeks, since lice cannot survive long without a blood meal and will die well within that window.[1] A single hot-dryer cycle on high heat (at least 30 minutes) is a reasonable faster option when a full wash is not immediately feasible. Pair this with regular bathing/showering and a genuine, ongoing change of clean clothing — sustained access, not a one-time cleaning event, is what actually prevents reinfestation.[1]
When a topical pediculicide is actually needed
Preferred, when lice or nits are found on body hair permethrin 1% creme rinse applied to the affected hair-bearing skin, left in place for 10 minutes, then rinsed off; repeat in 7-9 days if live lice are still seen — the same standard dosing used for head lice. Do not apply a pediculicide to intact, uninvolved skin, and do not use it as a substitute for clothing/bedding decontamination — a pediculicide alone, without laundering, does not clear a body lice infestation, because the louse population lives in the clothing, not on the person.[1] Alternative malathion 0.5% lotion applied to affected hair-bearing skin for 8-12 hours then washed off, reserved for permethrin-refractory infestation given its odour and flammability (avoid open flame or a hair dryer during use). Special situation oral ivermectin (used off-label; not a Health Canada-approved indication for lice) has been used for outbreak control in shelter settings where topical application to many residents at once is impractical — reserve for this specific situation, generally with specialist or public health input.
Symptomatic care
Pruritus a non-sedating oral antihistamine (cetirizine) for daytime use, or diphenhydramine at bedtime if nocturnal itching is prominent. Inflamed, excoriated skin a short course of low-potency topical hydrocortisone. Secondary bacterial skin infection treat per the usual impetigo/cellulitis pathway if present.
Suspected louse-borne systemic illness — treat urgently and notify public health
Suspected epidemic typhus doxycycline 100 mg PO twice daily until afebrile for 24-48 hours, typically 7-10 days total; chloramphenicol 500 mg PO/IV four times daily for 7-10 days is a documented alternative. Start treatment without waiting for serologic confirmation if the patient is seriously ill — early treatment essentially eliminates the risk of fatal illness.[5][6]
Suspected louse-borne relapsing fever a single dose of doxycycline 200 mg PO is the standard treatment specifically for louse-transmitted disease — genuinely different from, and much shorter than, the 10-day course used for tick-borne relapsing fever; tetracycline or erythromycin 500 mg PO as a single dose is a documented alternative.[8] Premedicating with acetaminophen 650 mg PO given 2 hours before and repeated 2 hours after the antibiotic dose has been used to reduce the severity of the Jarisch-Herxheimer reaction, which occurs in over half of patients and can include acute hemodynamic instability — treat in a setting equipped to monitor for and manage this reaction regardless of the specific antibiotic chosen, being prepared to resuscitate through the reaction rather than to withhold treatment.[8][3]
Suspected trench fever / Bartonella quintana bacteremia doxycycline 200 mg/day PO for 28 days combined with gentamicin 3 mg/kg/day IV for 14 days; for endocarditis, extend doxycycline to 6 weeks (100 mg PO twice daily) with the same 14-day gentamicin course — combination therapy with an aminoglycoside is associated with better clearance of bacteremia and better survival than doxycycline alone. If aminoglycoside toxicity is a specific concern, involve infectious diseases to select an alternative combination rather than simply omitting gentamicin without substitution.[2]
Non-Pharmacologic Treatment
Clothing and bedding decontamination — the core, non-negotiable intervention
- Hot-water wash plus high-heat dry for all clothing, bedding, and towels the patient has actually been wearing/using — at least 50°C (130°F) wash, followed by a full high-heat dry cycle.[1]
- Dry cleaning for items that cannot be machine washed.
- Sealed plastic bag for at least 2 weeks for items that can be neither washed nor dry-cleaned — lice die without a blood meal well within this window, and any remaining eggs will have hatched and died as well.[1]
- A single high-heat dryer cycle (at least 30 minutes) alone is a reasonable rapid option when laundering the item is genuinely not possible in the short term.
- Discard heavily infested items outright when a replacement can realistically be provided — many shelters and outreach programs can supply clean replacement clothing, which is often more practical than asking a patient to manage a multi-step decontamination process with very limited belongings.
- Body lice are not a broad household or furniture infestation the way bed bugs are — decontamination should focus specifically on the person's actual worn clothing and bedding, not on fumigating a living space.
Personal hygiene
Regular bathing or showering, together with a genuine, ongoing change of clean clothing (ideally at least weekly), is on its own sufficient to control body lice, and is the single most important preventer of recurrence.[1]
Addressing the access barrier — the actual determinant of whether treatment succeeds
Because body lice infestation is fundamentally a marker of limited access to bathing and clean clothing rather than a personal hygiene failure, a course of pediculicide or even a single successful laundering event will not prevent reinfestation if that underlying access barrier remains. Connect the patient with practical resources: shelter or drop-in laundry and shower facilities, clean-clothing exchange or donation programs, and outreach or public health nursing services already working with the local homeless-serving system. In congregate settings (shelters, correctional facilities), work with facility staff on routine screening and laundering protocols for residents, consistent with local public health infection-prevention-and-control guidance for these settings.
A non-stigmatizing approach
Frame body lice explicitly as a treatable medical condition tied to a real, addressable access barrier, not as a reflection of the patient's character or effort. Patients who have previously been shamed for a lice infestation are less likely to seek care early or to disclose ongoing symptoms — a matter-of-fact, practical approach measurably improves both the immediate encounter and the likelihood of a successful, lasting outcome.
Special Populations
Pregnancy
Favor non-pharmacologic management (clothing/bedding decontamination and hygiene access) as the primary approach in pregnancy, since this alone resolves most infestations. If a topical pediculicide is genuinely needed permethrin is generally preferred among pediculicide options in pregnancy, since only minimal systemic absorption occurs with topical use and animal studies at oral doses far higher than typical topical exposure have not shown fetal harm, though adequate controlled human studies are lacking.
Suspected louse-borne systemic illness in pregnancy do not withhold treatment for a genuinely life-threatening maternal infection. Louse-borne relapsing fever in particular carries a very high rate of adverse pregnancy outcomes — miscarriage, stillbirth, preterm delivery, or suspected congenital infection in roughly 3 of 4 reported pregnancies — so treating the maternal infection is itself protective of the pregnancy.[3] Involve obstetrics and infectious diseases immediately for antibiotic selection and monitoring in this situation.
Breastfeeding
Topical permethrin is considered compatible with breastfeeding given minimal systemic absorption. Short courses of doxycycline for a genuine systemic indication are generally considered compatible with breastfeeding by current expert sources, given limited calcium-mediated transfer into the infant through breast milk, though this should still be confirmed against the current product monograph and guidance at the time of use.
Pediatrics
Children in families experiencing homelessness or housing instability are also at risk and should be screened alongside affected adults. Confirm the age-appropriate minimum for any topical pediculicide against its product monograph before use in a young child. The decontamination approach (hot laundering, dry cleaning, or 2-week bagging) is identical regardless of age.
Older adults
Use diphenhydramine cautiously given its anticholinergic burden; cetirizine is generally the better-tolerated antihistamine choice in this group. Chronic vagabond's-disease skin changes and reduced skin integrity may make this population more prone to secondary bacterial infection from scratching — examine skin carefully.
Immunocompromised patients, including HIV
Maintain a lower threshold to investigate for a louse-borne systemic illness, since presentation can be more severe or atypical, and involve infectious diseases early.
Renal impairment
Adjust the gentamicin dose to renal function and monitor levels closely when it is used for confirmed B. quintana bacteremia or endocarditis — this combination is specifically valuable but carries real nephrotoxicity risk. Doxycycline generally requires no renal dose adjustment.
Monitoring & Follow-Up
Arrange follow-up at 1-2 weeks to confirm the infestation has actually resolved and, just as importantly, that clothing/bedding decontamination was genuinely achievable for the patient — ask directly rather than assuming, and offer further practical support (shelter laundry access, replacement clothing) if a barrier remains.
- Re-examine clothing seams for any persistent live lice or new nits.
- Assess skin healing and resolution of pruritus; screen for signs of secondary infection that may have developed after the initial visit.
- If a topical pediculicide was used for body-hair involvement, confirm whether retreatment at day 7-9 is indicated per the product's standard dosing schedule.
- Screen specifically for any interval fever, rash, or other systemic symptom at every follow-up contact — a louse-borne systemic illness can present after the skin infestation has already been treated.
- For any patient treated for epidemic typhus, trench fever, or louse-borne relapsing fever, confirm the full course was completed, that specialist follow-up (infectious diseases, and cardiology if endocarditis was involved) is arranged, and that the applicable public health notification and any required contact follow-up has actually been completed.[5][7]
- Beyond the immediate episode, the most important ongoing "monitoring" question is whether the patient now has a durable connection to clean clothing and bathing access — reassess and re-engage this at every subsequent contact, since it is what determines whether the infestation recurs.
Common Errors to Avoid
- Treating body lice with a topical pediculicide alone while never addressing clothing and bedding decontamination — since the lice population lives in the fabric, this leaves the actual source of the infestation untouched.
- Examining only the skin and hair, rather than the clothing seams, and missing the diagnosis (or misdiagnosing something else) as a result.
- Applying a pediculicide to intact skin by default rather than confirming lice or nits are genuinely present on body hair first.
- Using stigmatizing or moralizing language when discussing the diagnosis, which reduces the likelihood of early presentation and honest disclosure of ongoing symptoms.
- Attributing fever or a rash in a patient with body lice exposure to the skin infestation itself, rather than screening for epidemic typhus, trench fever, or louse-borne relapsing fever.
- Failing to notify public health when a louse-borne systemic illness is suspected or confirmed, or assuming this reporting requirement does not apply simply because typhus is not nationally notifiable in Canada — check and follow the specific notifiable-disease requirement in your own province or territory.
- Starting antibiotic treatment for suspected louse-borne relapsing fever without preparing to monitor for and manage the Jarisch-Herxheimer reaction, which occurs in over half of patients.
- Confusing body lice with head lice or pubic lice and applying a mismatched treatment (e.g., treating the scalp or pubic hair) when the actual infestation is in worn clothing.
- Recommending broad insecticide fumigation of a patient's living space — the mainstay of treatment is laundering the person's actual worn clothing and bedding, not treating furniture or the wider environment.
- Treating a single successful decontamination episode as the end of the encounter without addressing the patient's ongoing, real-world access to bathing and clean clothing, which is what actually prevents recurrence.
Clinical Decision Algorithm
Drug Tables
How to use this table: doses are adult doses and require patient-specific confirmation, including renal/hepatic adjustment. Select any drug name to open its complete Pharmasist Drug Database page.
Topical Pediculicides — For Confirmed Lice or Nits on Body Hair Only
Clothing and bedding decontamination is the actual core of treatment for body lice; a pediculicide is an adjunct used only when lice or nits are genuinely found on body hair, never a substitute for it.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Permethrin 1% creme rinse | Adults and children: 1% creme rinse to affected hair-bearing skin, single application, repeat day 7-9 PRN | Local irritation, pruritus, mild burning sensation | None significant at standard topical doses | Apply to affected hair-bearing skin, leave 10 minutes, rinse. Repeat in 7-9 days if live lice are still seen. |
| Malathion 0.5% lotion | Adults and children: Apply to affected hair-bearing skin, leave 8-12 hours, then wash off | Strong odour, skin irritation; flammable | None significant at standard topical doses | Reserve for permethrin-refractory infestation; avoid open flame or a hair dryer during the application period. |
| Ivermectin (oral) | Adults: Specialist-directed single dose | Dizziness, nausea, diarrhea | Increased sedation with other CNS depressants (theoretical) | Off-label; not a Health Canada-approved indication for lice. Reserve for outbreak control in a congregate/shelter setting under specialist or public health direction. |
Symptomatic Relief
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Cetirizine | Adults: 10 mg PO once daily | Mild sedation, dry mouth, fatigue | Additive sedation with other CNS depressants | Preferred over diphenhydramine for daytime pruritus given its lower sedation profile. |
| Diphenhydramine | Adults: 25-50 mg PO at bedtime PRN | Sedation, anticholinergic effects (dry mouth, urinary retention, constipation) | Additive sedation with other CNS depressants; additive anticholinergic burden with other anticholinergic drugs | Reserve for nocturnal pruritus; use cautiously in older adults given anticholinergic burden. |
| Hydrocortisone (topical) | Adults and children: 1% cream applied twice daily, short course | Local skin thinning, striae, or telangiectasia with prolonged use | None significant at standard topical doses | Short courses only for inflamed, excoriated skin — not a substitute for delousing. |
Epidemic Typhus (Rickettsia prowazekii) — Systemic Antibiotic Therapy
Start treatment without waiting for laboratory confirmation if the patient is seriously ill; early treatment essentially eliminates the risk of fatal illness. This is a reportable illness — notify public health.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Doxycycline | Adults: 100 mg PO twice daily, typically 7-10 days total | Photosensitivity, GI upset, esophageal irritation | Reduced absorption with antacids/dairy/metal cations; may increase INR with warfarin | Preferred first-line agent; continue until the patient has been afebrile for 24-48 hours. |
| Chloramphenicol | Adults: 500 mg PO or IV four times daily for 7-10 days | Bone marrow suppression (including aplastic anemia), GI upset, gray baby syndrome in neonates | May increase phenytoin, warfarin, and sulfonylurea levels via CYP inhibition | Documented alternative when doxycycline cannot be used. |
Trench Fever (Bartonella quintana) — Systemic Antibiotic Therapy
Combination therapy with an aminoglycoside improves bacteremia clearance and survival compared with doxycycline alone, particularly in endocarditis.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Doxycycline | Chronic bacteremia: 200 mg/day PO for 28 days Endocarditis: 100 mg PO twice daily for 6 weeks | Photosensitivity, GI upset, esophageal irritation | Reduced absorption with antacids/dairy/metal cations; may increase INR with warfarin | Combine with gentamicin. Longer courses than for typhus given the risk of relapse and endocarditis. |
| Gentamicin | Adults: 3 mg/kg/day IV for 14 days | Nephrotoxicity, ototoxicity | Additive nephro/ototoxicity with vancomycin or other nephrotoxic drugs | Monitor levels and renal function closely; the aminoglycoside component measurably improves outcomes and should not be omitted without a specific reason. |
Louse-Borne Relapsing Fever (Borrelia recurrentis) — Systemic Antibiotic Therapy
The louse-borne-specific single-dose regimen is genuinely different from, and much shorter than, the multi-day course used for tick-borne relapsing fever. Treat only in a setting equipped to monitor for and manage the Jarisch-Herxheimer reaction, which occurs in over half of patients.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Doxycycline | Adults: 200 mg PO, single dose | Photosensitivity, GI upset; may precipitate a Jarisch-Herxheimer reaction | Reduced absorption with antacids/dairy/metal cations; may increase INR with warfarin | A single oral dose is the complete treatment for louse-borne disease — do not extend to a multi-day course, which is the tick-borne regimen instead. |
References
- Pediculosis Corporis — StatPearls, National Library of Medicine (Powers J, Badri T, Syed HA). StatPearls [Internet], updated February 12, 2024
- Bartonella quintana Characteristics and Clinical Management — Emerging Infectious Diseases (Foucault C, Brouqui P, Raoult D). Emerg Infect Dis 2006;12(2):217-223
- Louse-borne relapsing fever - A systematic review and analysis of the literature: Part 2 - Mortality, Jarisch-Herxheimer reaction, impact on pregnancy — PLOS Neglected Tropical Diseases (Kahlig P, Neumayr A, Paris DH). PLoS Negl Trop Dis 2021;15(3):e0008656
- Body Louse Pathogen Surveillance among Persons Experiencing Homelessness, Canada, 2020-2021 — Emerging Infectious Diseases, Public Health Agency of Canada / University of Manitoba (Boodman C, Lindsay LR, Dibernardo A, Kisil K, Coatsworth H, Huynh C, Heendeniya A, Schellenberg J, Keynan Y). Emerg Infect Dis 2024;30(7):1450-1453
- Public Health Disease Management Guidelines: Typhus - Louseborne — Alberta Health. Alberta Health Public Health Disease Management Guidelines, reporting requirements revised May 2018
- Rickettsia Prowazekii — StatPearls, National Library of Medicine (Akram SM, Ladd M, King KC). StatPearls [Internet], updated August 8, 2023
- Public Health Notifiable Disease Management Guidelines: Relapsing Fever, Louseborne — Alberta Health. Alberta Health Public Health Notifiable Disease Management Guidelines, January 2013
- Relapsing Fever — Merck Manual Professional Edition (Bush LM, Vazquez-Pertejo MT). Merck Manual Professional Edition, reviewed/revised January 2025
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.